Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Issue of shares, Director/PDMR Shareholding & TVR

13th Apr 2022 12:00

RNS Number : 2953I
Ideagen PLC
13 April 2022
 

13 April 2022

Ideagen PLC

("Ideagen," "the Company" or the "Group'')

Issue of new shares under the Share Incentive Plan, Director/PDMR Shareholding and Total Voting Rights

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, announces that it has allotted a total of 4,577 new ordinary shares of 1 penny each in the capital of the Company ("Ordinary Shares") following the purchase of 4,577 Ordinary Shares in aggregate by a number of employees under the Company's Share Incentive Plan ("SIP").

Application has been made to the London Stock Exchange for the 4,577 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8.00 a.m. on 21 April 2022.

After Admission, the total number of Ordinary Shares in issue will be 293,749,829 and the total number of voting rights will therefore be 293,749,829. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

In addition, following the automatic reinvestment of the Company's recent dividend by his nominated broker, Alan Carroll, a non-executive director, has purchased 24 Ordinary Shares at a price of £2.517.

Following the above acquisition, Mr Carroll's beneficial interest has increased to 204,487 shares representing approximately 0.07% of the Company's issued ordinary share capital.

Enquiries:

Ideagen plc

01629 699 100

Ben Dorks, Chief Executive Officer

Emma Hayes, Chief Financial Officer

 

Canaccord Genuity Limited (Nomad)

020 7523 8000

Simon Bridges

Georgina McCooke

finnCap Limited

020 7220 0500

Henrik Persson/James Thompson

Alice Lane

 

Numis Securities Limited

0207 260 1267

Simon Willis

Joshua Hughes

FTI Consulting

020 3727 1000

Jamie Ricketts

[email protected]

Dwight Burden

Valerija Cymbal

About Ideagen plc

Ideagen's software helps companies comply with regulation and manage risk.

Ideagen is a leader in the +$30 billion regulatory and compliance software market, serving highly regulated industries such as life sciences, healthcare, banking and finance and insurance.

More than 8,000 customers use Ideagen's software, including 9 of the top 10 UK accounting firms, all of the top aerospace and defence companies and 75% of leading pharmaceutical firms.

Ideagen has a diversified customer base including blue chip, global brands such as Heineken, British Airways, BAE, Aggreko, US Navy, Bank of New York and Johnson Matthey, as well as 250 hospitals across the UK and US.

Ideagen is headquartered in the UK, listed on the London Stock Exchange AIM market (Ticker: IDEA.L), and has key hubs in the UK, USA, Middle East and South East Asia. For further information please visit www.ideagen.com.

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Alan Carroll

2.

Reason for the Notification

a)

Position/status

Non-executive Director and PDMR

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ideagen plc

b)

LEI

213800KS1MLITOVNYC85

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 1p each

Identification code

GB00B0CM0C50

b)

Nature of the transaction

Purchase of Ordinary shares

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

251.7 pence

24

d)

Aggregated information:

· Aggregated volume

· Price

24 Ordinary shares purchased at 251.7p per share

e)

Date of the transaction

12 April 2022

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEIJMMTMTABBRT

Related Shares:

IDEA.L
FTSE 100 Latest
Value8,275.66
Change0.00